https://www.selleckchem.com/products/ots514.html
Due to the increasing incidence of metabolic syndrome, the development of new therapeutic strategies is urgently required. One promising approach is to focus on the predisease state (so-called Mibyou in traditional Japanese medicine) before metabolic syndrome as a preemptive medical target. We recently succeeded in detecting a predisease state before metabolic syndrome using a mathematical theory called the dynamical network biomarker (DN theory. The detected predisease state was characterized by 147 DNB genes among a total of 24,217 g
Like
Comment
Share
